Marginal Zone Lymphoma

Oncology·MeSH: Lymphoma, Large B-Cell, Diffuse

Prevalence

56.0 / 100K

Incidence

19.6 / 100K/yr

5 drugs in development·3 companies·25 clinical trials

Drug Pipeline by Phase

Compare drugs

bendamustine vs mosunetuzumabbendamustine vs zilovertamabbendamustine vs Orelabrutinib combined with obinutuzumab

Frequently asked questions

How many drugs are in development for Marginal Zone Lymphoma?

BioSniper tracks 5 drugs in development for Marginal Zone Lymphoma across 3 companies.

How many clinical trials target Marginal Zone Lymphoma?

There are 25 clinical trials targeting Marginal Zone Lymphoma tracked by BioSniper.

What is the prevalence of Marginal Zone Lymphoma?

The estimated prevalence of Marginal Zone Lymphoma is approximately 56.0 per 100,000 population.

Deep-dive into Marginal Zone Lymphoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Marginal Zone Lymphoma — Drugs in Development & Clinical Trials | BioSniper